Selected research
Industry Research
Dog Pharmaceuticals and Supplements Industry Research Report 2026
Market perspective
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dog Pharmaceuticals and Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dog Pharmaceuticals and Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dog Pharmaceuticals and Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dog Pharmaceuticals and Supplements include Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation and Manna Pro Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dog Pharmaceuticals and Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dog Pharmaceuticals and Supplements Market by Company
Virbac
Zoetis
Vetoquinol
Nestle Purina
NOW Foods
Nutramax Laboratories
Bayer
Foodscience corporation
Manna Pro Products
Ark Naturals
Blackmores
Zesty Paws
Nuvetlabs
Mavlab
Vetafarm
Nupro Supplements
Dog Pharmaceuticals and Supplements Segment by Type
Pharmaceuticals
Supplements
Dog Pharmaceuticals and Supplements Segment by Application
Puppy
Adult Dogs
Dog Pharmaceuticals and Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dog Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Pharmaceuticals and Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dog Pharmaceuticals and Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dog Pharmaceuticals and Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dog Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Dog Pharmaceuticals and Supplements Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Dog Pharmaceuticals and Supplements Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Dog Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Dog Pharmaceuticals and Supplements Revenue of Manufacturers (2021-2026)
Table 9. Global Dog Pharmaceuticals and Supplements Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Dog Pharmaceuticals and Supplements Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Dog Pharmaceuticals and Supplements Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Dog Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Dog Pharmaceuticals and Supplements, Product Type & Application
Table 14. Global Dog Pharmaceuticals and Supplements Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Dog Pharmaceuticals and Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Virbac Company Information
Table 19. Virbac Business Overview
Table 20. Virbac Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Virbac Dog Pharmaceuticals and Supplements Product Portfolio
Table 22. Virbac Recent Developments
Table 23. Zoetis Company Information
Table 24. Zoetis Business Overview
Table 25. Zoetis Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Zoetis Dog Pharmaceuticals and Supplements Product Portfolio
Table 27. Zoetis Recent Developments
Table 28. Vetoquinol Company Information
Table 29. Vetoquinol Business Overview
Table 30. Vetoquinol Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Vetoquinol Dog Pharmaceuticals and Supplements Product Portfolio
Table 32. Vetoquinol Recent Developments
Table 33. Nestle Purina Company Information
Table 34. Nestle Purina Business Overview
Table 35. Nestle Purina Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Nestle Purina Dog Pharmaceuticals and Supplements Product Portfolio
Table 37. Nestle Purina Recent Developments
Table 38. NOW Foods Company Information
Table 39. NOW Foods Business Overview
Table 40. NOW Foods Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. NOW Foods Dog Pharmaceuticals and Supplements Product Portfolio
Table 42. NOW Foods Recent Developments
Table 43. Nutramax Laboratories Company Information
Table 44. Nutramax Laboratories Business Overview
Table 45. Nutramax Laboratories Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Nutramax Laboratories Dog Pharmaceuticals and Supplements Product Portfolio
Table 47. Nutramax Laboratories Recent Developments
Table 48. Bayer Company Information
Table 49. Bayer Business Overview
Table 50. Bayer Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Bayer Dog Pharmaceuticals and Supplements Product Portfolio
Table 52. Bayer Recent Developments
Table 53. Foodscience corporation Company Information
Table 54. Foodscience corporation Business Overview
Table 55. Foodscience corporation Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Foodscience corporation Dog Pharmaceuticals and Supplements Product Portfolio
Table 57. Foodscience corporation Recent Developments
Table 58. Manna Pro Products Company Information
Table 59. Manna Pro Products Business Overview
Table 60. Manna Pro Products Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Manna Pro Products Dog Pharmaceuticals and Supplements Product Portfolio
Table 62. Manna Pro Products Recent Developments
Table 63. Ark Naturals Company Information
Table 64. Ark Naturals Business Overview
Table 65. Ark Naturals Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Ark Naturals Dog Pharmaceuticals and Supplements Product Portfolio
Table 67. Ark Naturals Recent Developments
Table 68. Blackmores Company Information
Table 69. Blackmores Business Overview
Table 70. Blackmores Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Blackmores Dog Pharmaceuticals and Supplements Product Portfolio
Table 72. Blackmores Recent Developments
Table 73. Zesty Paws Company Information
Table 74. Zesty Paws Business Overview
Table 75. Zesty Paws Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Zesty Paws Dog Pharmaceuticals and Supplements Product Portfolio
Table 77. Zesty Paws Recent Developments
Table 78. Nuvetlabs Company Information
Table 79. Nuvetlabs Business Overview
Table 80. Nuvetlabs Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Nuvetlabs Dog Pharmaceuticals and Supplements Product Portfolio
Table 82. Nuvetlabs Recent Developments
Table 83. Mavlab Company Information
Table 84. Mavlab Business Overview
Table 85. Mavlab Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Mavlab Dog Pharmaceuticals and Supplements Product Portfolio
Table 87. Mavlab Recent Developments
Table 88. Vetafarm Company Information
Table 89. Vetafarm Business Overview
Table 90. Vetafarm Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. Vetafarm Dog Pharmaceuticals and Supplements Product Portfolio
Table 92. Vetafarm Recent Developments
Table 93. Nupro Supplements Company Information
Table 94. Nupro Supplements Business Overview
Table 95. Nupro Supplements Dog Pharmaceuticals and Supplements Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Nupro Supplements Dog Pharmaceuticals and Supplements Product Portfolio
Table 97. Nupro Supplements Recent Developments
Table 98. Global Dog Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 99. Global Dog Pharmaceuticals and Supplements Sales by Region (2021-2026) & (k units)
Table 100. Global Dog Pharmaceuticals and Supplements Sales Market Share by Region (2021-2026)
Table 101. Global Dog Pharmaceuticals and Supplements Sales by Region (2027-2032) & (k units)
Table 102. Global Dog Pharmaceuticals and Supplements Sales Market Share by Region (2027-2032)
Table 103. Global Dog Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million)
Table 104. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2021-2026)
Table 105. Global Dog Pharmaceuticals and Supplements Revenue by Region (2027-2032) & (US$ Million)
Table 106. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Region (2027-2032)
Table 107. North America Dog Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. North America Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units)
Table 109. North America Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units)
Table 110. North America Dog Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)
Table 111. North America Dog Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million)
Table 112. Europe Dog Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Europe Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units)
Table 114. Europe Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units)
Table 115. Europe Dog Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)
Table 116. Europe Dog Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million)
Table 117. Asia Pacific Dog Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units)
Table 119. Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units)
Table 120. Asia Pacific Dog Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)
Table 121. Asia Pacific Dog Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million)
Table 122. South America Dog Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. South America Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units)
Table 124. South America Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units)
Table 125. South America Dog Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)
Table 126. South America Dog Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million)
Table 127. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2021-2026) & (k units)
Table 129. Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2027-2032) & (k units)
Table 130. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)
Table 131. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue by Country (2027-2032) & (US$ Million)
Table 132. Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2026) & (k units)
Table 133. Global Dog Pharmaceuticals and Supplements Sales by Type (2027-2032) & (k units)
Table 134. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2026)
Table 135. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2027-2032)
Table 136. Global Dog Pharmaceuticals and Supplements Revenue by Type (2021-2026) & (US$ Million)
Table 137. Global Dog Pharmaceuticals and Supplements Revenue by Type (2027-2032) & (US$ Million)
Table 138. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2026)
Table 139. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2027-2032)
Table 140. Global Dog Pharmaceuticals and Supplements Price by Type (2021-2026) & (USD/unit)
Table 141. Global Dog Pharmaceuticals and Supplements Price by Type (2027-2032) & (USD/unit)
Table 142. Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2026) & (k units)
Table 143. Global Dog Pharmaceuticals and Supplements Sales by Application (2027-2032) & (k units)
Table 144. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2026)
Table 145. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2027-2032)
Table 146. Global Dog Pharmaceuticals and Supplements Revenue by Application (2021-2026) & (US$ Million)
Table 147. Global Dog Pharmaceuticals and Supplements Revenue by Application (2027-2032) & (US$ Million)
Table 148. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2026)
Table 149. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2027-2032)
Table 150. Global Dog Pharmaceuticals and Supplements Price by Application (2021-2026) & (USD/unit)
Table 151. Global Dog Pharmaceuticals and Supplements Price by Application (2027-2032) & (USD/unit)
Table 152. Key Raw Materials
Table 153. Raw Materials Key Suppliers
Table 154. Dog Pharmaceuticals and Supplements Distributors List
Table 155. Dog Pharmaceuticals and Supplements Customers List
Table 156. Dog Pharmaceuticals and Supplements Industry Trends
Table 157. Dog Pharmaceuticals and Supplements Industry Drivers
Table 158. Dog Pharmaceuticals and Supplements Industry Restraints
Table 159. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dog Pharmaceuticals and Supplements Product Image
Figure 5. Global Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Dog Pharmaceuticals and Supplements Market Size (2021-2032) & (US$ Million)
Figure 7. Global Dog Pharmaceuticals and Supplements Sales (2021-2032) & (k units)
Figure 8. Global Dog Pharmaceuticals and Supplements Average Price (USD/unit) & (2021-2032)
Figure 9. Pharmaceuticals Product Image
Figure 10. Supplements Product Image
Figure 11. Puppy Product Image
Figure 12. Adult Dogs Product Image
Figure 13. Global Dog Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2025
Figure 14. Global Manufacturers of Dog Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Dog Pharmaceuticals and Supplements Players Market Share by Revenue in 2025
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 17. Global Dog Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 18. Global Dog Pharmaceuticals and Supplements Sales by Region in 2025
Figure 19. Global Dog Pharmaceuticals and Supplements Revenue by Region in 2025
Figure 20. North America Dog Pharmaceuticals and Supplements Market Size by Country in 2025
Figure 21. North America Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032)
Figure 22. North America Dog Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032)
Figure 23. United States Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 24. Canada Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Mexico Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Dog Pharmaceuticals and Supplements Market Size by Country in 2025
Figure 27. Europe Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032)
Figure 28. Europe Dog Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032)
Figure 29. Germany Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Russia Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Spain Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Netherlands Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Switzerland Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Sweden Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Poland Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Asia Pacific Dog Pharmaceuticals and Supplements Market Size by Country in 2025
Figure 40. Asia Pacific Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032)
Figure 41. Asia Pacific Dog Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032)
Figure 42. China Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Japan Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. South Korea Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. India Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Australia Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Taiwan Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South America Dog Pharmaceuticals and Supplements Market Size by Country in 2025
Figure 51. South America Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032)
Figure 52. South America Dog Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032)
Figure 53. Brazil Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Argentina Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Chile Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Middle East and Africa Dog Pharmaceuticals and Supplements Market Size by Country in 2025
Figure 57. Middle East and Africa Dog Pharmaceuticals and Supplements Sales Market Share by Country (2021-2032)
Figure 58. Middle East and Africa Dog Pharmaceuticals and Supplements Revenue Market Share by Country (2021-2032)
Figure 59. Egypt Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. South Africa Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Israel Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Türkiye Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. GCC Countries Dog Pharmaceuticals and Supplements Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
Figure 65. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
Figure 66. Global Dog Pharmaceuticals and Supplements Price (USD/unit) by Type (2021-2032)
Figure 67. Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
Figure 68. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
Figure 69. Global Dog Pharmaceuticals and Supplements Price (USD/unit) by Application (2021-2032)
Figure 70. Dog Pharmaceuticals and Supplements Value Chain
Figure 71. Dog Pharmaceuticals and Supplements Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Dog Pharmaceuticals and Supplements Industry Opportunities and Challenges
Scope & coverage.
Types
- Pharmaceuticals
- Supplements
Applications
- Puppy
- Adult Dogs
Companies covered
- Virbac
- Zoetis
- Vetoquinol
- Nestle Purina
- NOW Foods
- Nutramax Laboratories
- Bayer
- Foodscience corporation
- Manna Pro Products
- Ark Naturals
- Blackmores
- Zesty Paws
- Nuvetlabs
- Mavlab
- Vetafarm
- Nupro Supplements
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dog Pharmaceuticals and Supplements Market Size (2021-2032)
- 2.2.2 Global Dog Pharmaceuticals and Supplements Sales (2021-2032)
- 2.2.3 Global Dog Pharmaceuticals and Supplements Market Average Price (2021-2032)
- 2.3 Dog Pharmaceuticals and Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceuticals
- 2.3.3 Supplements
- 2.4 Dog Pharmaceuticals and Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Puppy
- 2.4.3 Adult Dogs
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dog Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dog Pharmaceuticals and Supplements Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Dog Pharmaceuticals and Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Dog Pharmaceuticals and Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Dog Pharmaceuticals and Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dog Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dog Pharmaceuticals and Supplements, Product Type & Application
- 3.8 Global Manufacturers of Dog Pharmaceuticals and Supplements, Established Date
- 3.9 Global Dog Pharmaceuticals and Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Virbac
- 4.1.1 Virbac Company Information
- 4.1.2 Virbac Business Overview
- 4.1.3 Virbac Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Virbac Dog Pharmaceuticals and Supplements Product Portfolio
- 4.1.5 Virbac Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Dog Pharmaceuticals and Supplements Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Vetoquinol
- 4.3.1 Vetoquinol Company Information
- 4.3.2 Vetoquinol Business Overview
- 4.3.3 Vetoquinol Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vetoquinol Dog Pharmaceuticals and Supplements Product Portfolio
- 4.3.5 Vetoquinol Recent Developments
- 4.4 Nestle Purina
- 4.4.1 Nestle Purina Company Information
- 4.4.2 Nestle Purina Business Overview
- 4.4.3 Nestle Purina Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nestle Purina Dog Pharmaceuticals and Supplements Product Portfolio
- 4.4.5 Nestle Purina Recent Developments
- 4.5 NOW Foods
- 4.5.1 NOW Foods Company Information
- 4.5.2 NOW Foods Business Overview
- 4.5.3 NOW Foods Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NOW Foods Dog Pharmaceuticals and Supplements Product Portfolio
- 4.5.5 NOW Foods Recent Developments
- 4.6 Nutramax Laboratories
- 4.6.1 Nutramax Laboratories Company Information
- 4.6.2 Nutramax Laboratories Business Overview
- 4.6.3 Nutramax Laboratories Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nutramax Laboratories Dog Pharmaceuticals and Supplements Product Portfolio
- 4.6.5 Nutramax Laboratories Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Dog Pharmaceuticals and Supplements Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Foodscience corporation
- 4.8.1 Foodscience corporation Company Information
- 4.8.2 Foodscience corporation Business Overview
- 4.8.3 Foodscience corporation Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Foodscience corporation Dog Pharmaceuticals and Supplements Product Portfolio
- 4.8.5 Foodscience corporation Recent Developments
- 4.9 Manna Pro Products
- 4.9.1 Manna Pro Products Company Information
- 4.9.2 Manna Pro Products Business Overview
- 4.9.3 Manna Pro Products Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Manna Pro Products Dog Pharmaceuticals and Supplements Product Portfolio
- 4.9.5 Manna Pro Products Recent Developments
- 4.10 Ark Naturals
- 4.10.1 Ark Naturals Company Information
- 4.10.2 Ark Naturals Business Overview
- 4.10.3 Ark Naturals Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ark Naturals Dog Pharmaceuticals and Supplements Product Portfolio
- 4.10.5 Ark Naturals Recent Developments
- 4.11 Blackmores
- 4.11.1 Blackmores Company Information
- 4.11.2 Blackmores Business Overview
- 4.11.3 Blackmores Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Blackmores Dog Pharmaceuticals and Supplements Product Portfolio
- 4.11.5 Blackmores Recent Developments
- 4.12 Zesty Paws
- 4.12.1 Zesty Paws Company Information
- 4.12.2 Zesty Paws Business Overview
- 4.12.3 Zesty Paws Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Zesty Paws Dog Pharmaceuticals and Supplements Product Portfolio
- 4.12.5 Zesty Paws Recent Developments
- 4.13 Nuvetlabs
- 4.13.1 Nuvetlabs Company Information
- 4.13.2 Nuvetlabs Business Overview
- 4.13.3 Nuvetlabs Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nuvetlabs Dog Pharmaceuticals and Supplements Product Portfolio
- 4.13.5 Nuvetlabs Recent Developments
- 4.14 Mavlab
- 4.14.1 Mavlab Company Information
- 4.14.2 Mavlab Business Overview
- 4.14.3 Mavlab Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Mavlab Dog Pharmaceuticals and Supplements Product Portfolio
- 4.14.5 Mavlab Recent Developments
- 4.15 Vetafarm
- 4.15.1 Vetafarm Company Information
- 4.15.2 Vetafarm Business Overview
- 4.15.3 Vetafarm Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Vetafarm Dog Pharmaceuticals and Supplements Product Portfolio
- 4.15.5 Vetafarm Recent Developments
- 4.16 Nupro Supplements
- 4.16.1 Nupro Supplements Company Information
- 4.16.2 Nupro Supplements Business Overview
- 4.16.3 Nupro Supplements Dog Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Nupro Supplements Dog Pharmaceuticals and Supplements Product Portfolio
- 4.16.5 Nupro Supplements Recent Developments
5 Global Dog Pharmaceuticals and Supplements Market Scenario by Region
- 5.1 Global Dog Pharmaceuticals and Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dog Pharmaceuticals and Supplements Sales by Region: 2021-2032
- 5.2.1 Global Dog Pharmaceuticals and Supplements Sales by Region: 2021-2026
- 5.2.2 Global Dog Pharmaceuticals and Supplements Sales by Region: 2027-2032
- 5.3 Global Dog Pharmaceuticals and Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Dog Pharmaceuticals and Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Dog Pharmaceuticals and Supplements Revenue by Region: 2027-2032
- 5.4 North America Dog Pharmaceuticals and Supplements Market Facts & Figures by Country
- 5.4.1 North America Dog Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
- 5.4.3 North America Dog Pharmaceuticals and Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Dog Pharmaceuticals and Supplements Market Facts & Figures by Country
- 5.5.1 Europe Dog Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Dog Pharmaceuticals and Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Dog Pharmaceuticals and Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dog Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dog Pharmaceuticals and Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dog Pharmaceuticals and Supplements Market Facts & Figures by Country
- 5.7.1 South America Dog Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
- 5.7.3 South America Dog Pharmaceuticals and Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Dog Pharmaceuticals and Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dog Pharmaceuticals and Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dog Pharmaceuticals and Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dog Pharmaceuticals and Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2032)
- 6.1.1 Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Dog Pharmaceuticals and Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Dog Pharmaceuticals and Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Dog Pharmaceuticals and Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Dog Pharmaceuticals and Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2032)
- 7.1.1 Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Dog Pharmaceuticals and Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Dog Pharmaceuticals and Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Dog Pharmaceuticals and Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dog Pharmaceuticals and Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Dog Pharmaceuticals and Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dog Pharmaceuticals and Supplements Value Chain Analysis
- 8.1.1 Dog Pharmaceuticals and Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dog Pharmaceuticals and Supplements Production Mode & Process
- 8.2 Dog Pharmaceuticals and Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dog Pharmaceuticals and Supplements Distributors
- 8.2.3 Dog Pharmaceuticals and Supplements Customers
9 Global Dog Pharmaceuticals and Supplements Analyzing Market Dynamics
- 9.1 Dog Pharmaceuticals and Supplements Industry Trends
- 9.2 Dog Pharmaceuticals and Supplements Industry Drivers
- 9.3 Dog Pharmaceuticals and Supplements Industry Opportunities and Challenges
- 9.4 Dog Pharmaceuticals and Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst